DRY AGE-RELATED MACULAR DEGENERATION
Clinical trials for DRY AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new DRY AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for DRY AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eye implant trial offers hope for dry AMD patients
Disease control Recruiting nowThis study tests an experimental implant placed under the retina to treat advanced dry age-related macular degeneration (geographic atrophy). About 24 people aged 55-90 will take part, with most receiving the implant and a few receiving a sham procedure. The goal is to see if the…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Regenerative Patch Technologies, LLC • Aim: Disease control
Last updated May 26, 2026 08:23 UTC
-
Stem cells injected into eye to fight blindness: new trial launches
Disease control Recruiting nowThis early-stage trial tests if replacing damaged eye cells with lab-grown stem cells can help people with dry age-related macular degeneration and geographic atrophy. About 20 adults aged 55 and older will receive a transplant of their own reprogrammed cells into one eye. The ma…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated May 26, 2026 08:12 UTC
-
Cord blood plasma eyed as treatment for dry AMD
Disease control Recruiting nowThis study tests if injections of a substance made from umbilical cord blood (called platelet-rich plasma) can slow the worsening of dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. About 36 people aged 65 and older with dry AMD in both e…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated May 26, 2026 08:11 UTC
-
Stem cells injected into the eye to fight vision loss from dry AMD
Disease control Recruiting nowThis early-stage study tests whether transplanting special stem cells (RPESC-RPE) into the eye is safe for people with dry age-related macular degeneration (AMD), a common cause of vision loss. About 18 adults over age 55 will receive the cell transplant during eye surgery. The m…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Luxa Biotechnology, LLC • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Cord blood injection may halt dry AMD progression
Disease control Recruiting nowThis study tests whether injecting a special solution made from umbilical cord blood and platelet-rich plasma into the eye can slow or stop the worsening of dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. About 36 people aged 65 and olde…
Matched conditions: DRY AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated May 22, 2026 13:52 UTC